Show simple item record

dc.contributor.author Jorgo, Kliton
dc.contributor.author Ágoston, Péter Zoltán
dc.contributor.author Jánváry, Levente
dc.contributor.author Gesztesi, László
dc.contributor.author Stelczer, Gábor
dc.contributor.author Kontra, Gábor
dc.contributor.author Major, Tibor
dc.contributor.author Polgár, Csaba
dc.date.accessioned 2019-10-14T08:55:15Z
dc.date.available 2019-10-14T08:55:15Z
dc.date.issued 2019
dc.identifier.citation journalVolume=63;journalIssueNumber=1;journalTitle=MAGYAR ONKOLÓGIA;pagerange=52-59;journalAbbreviatedTitle=MAGYAR ONKOLÓGIA;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/7846
dc.description.abstract We report implementation of stereotactic body radiotherapy (SBRT) for the treatment of early, localized prostate cancer patients, and acute side effects caused by radiation therapy. Between February 2018 and July 2018, 36 prostate cancer patients were treated with SBRT. Treatments were performed with "CyberKnife M6" linear accelerator. In low-risk patients 8 Gy was delivered to the prostate in each fraction. For intermediate risk, 8 Gy to the prostate and 6.5 Gy to the seminal vesicles were delivered by each fraction with a simultaneous integrated boost technique. A total of 5 fractions (total dose 40 Gy) were given every second working days. Acute radiogenic genitourinary (GU) and gastrointestinal (GI) side effects were assessed using the Radiation Therapy Oncology Group (RTOG) score. The duration of radiotherapy was 1 week and 3 days. The frequency of acute radiogenic side effects was as follows: GU grade 0: 13.9%, grade I: 30.6%, grade II: 52.8%, grade III: 2.7%. GI grade 0: 55.5%, grade I: 30.6%, grade II: 13.9%, grade III: 0%. Grade IV-V side effects were not observed. SBRT appears to be a safe and well tolerated treatment in patients with early stage, localized prostate cancer.
dc.format.extent 52-59
dc.relation.ispartof urn:issn:0025-0244
dc.title Kis és közepes kockázatú prosztatarákos betegek sztereotaxiás sugárkezelése CyberKnife gyorsítóval: korai radiogén mellékhatások
dc.type Journal Article
dc.date.updated 2019-09-26T08:42:43Z
dc.language.rfc3066 hu
dc.rights.holder NULL
dc.identifier.mtmt 30625446
dc.identifier.pubmed 30889621
dc.contributor.department SE/AOK/K/Onkológiai Tanszék
dc.contributor.institution Semmelweis Egyetem


Files in this item

This file is available only from Semmelweis network

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account